E. coli Transformant for Itaconate via Nonphosphorylative Pathway
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing itaconate using Escherichia coli require additional protein nutrients like yeast extract or glutamate to overcome isocitrate dehydrogenase gene inhibition, leading to increased production costs.
Innovation Solution
Development of an Escherichia coli transformant with a constructed nonphosphorylative metabolic pathway using genes from Burkholderia xenovorans, which enables the bacterium to convert xylose into α-ketoglutaric acid and subsequently produce itaconate without the need for additional protein nutrients by incorporating genes such as D-xylose dehydrogenase, D-xylonate dehydratase, and 2-ketoglutarate semialdehyde dehydrogenase, and deleting isocitrate dehydrogenase.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If the icd gene is inhibited to accumulate precursors for itaconate production, then itaconate production capability is improved, but the strain becomes unable to grow and produce IA in basal medium due to auxotrophy
Solution Approach 1:
The patent introduces a heterologous non-phosphorylative pathway from Burkholderia xenovorans as an intermediary system to supply α-ketoglutarate. This alternative pathway acts as a mediator that bypasses the blocked isocitrate dehydrogenase step, providing necessary precursors for both growth and itaconate production without requiring external protein supplements.
Solution Approach 2:
The patent segments the metabolic pathway by separating the itaconate production pathway from the central metabolism. By deleting icd and introducing the non-phosphorylative pathway genes (xylA, yjhH, yagE), the system divides metabolic functions into distinct modules: one for maintaining growth through alternative α-ketoglutarate synthesis and another for itaconate production, allowing independent optimization of each function.
2Reliability
If protein nutrients are added to support strain growth, then strain growth capability is improved, but production costs increase
Solution Approach 1:
The engineered E. coli strain achieves self-sufficiency by containing all necessary genetic elements for synthesizing α-ketoglutarate through the introduced non-phosphorylative pathway. The strain no longer requires external protein nutrients like yeast extract or glutamate supplementation, as it can autonomously produce the required precursors through its modified metabolic pathway, thereby eliminating additional production costs.
3Productivity
If traditional Aspergillus terreus is used for itaconate production, then itaconate can be produced, but growth is slow and production efficiency is low during sporulation period
Solution Approach 1:
The patent copies the non-phosphorylative pathway gene cluster from Burkholderia xenovorans and introduces it into E. coli. This genetic copying allows the utilization of a fast-growing bacterial system (E. coli with generation time of 20-30 minutes) instead of the slow-growing fungus A. terreus, while maintaining the capability for efficient itaconate production through the transferred metabolic pathway.
Applied Scientific Principles
This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.
Function Achieved in This Case
The Escherichia coli transformant optimizes cell growth and itaconate production, achieving yields of 1.2 g/L within 24 hours and 20.01 g/L within 90 hours in a bioreactor, reducing production costs and eliminating the need for supplementary nutrients.
Implementation Method 1
the nonphosphorylative pathway of Burkholderia xenovorans in Escherichia coli, enables the strain to self-convert to synthesize α-ketoglutaric acid and further synthesize glutamate by metabolizing xylose
Implementation Method 2
a D-xylose dehydrogenase (XDH) gene
Implementation Method 3
a D-xylonolactonase (XL) gene
Implementation Method 4
a 2-keto-3-deoxy-D-xylonate dehydratase (KdxD) gene
Implementation Method 5
a 2-ketoglutarate semialdehyde dehydrogenase (KGSADH) gene
Data Source
AI summary
The present disclosure provides an Escherichia coli transformant and a method for producing itaconate using the Escherichia coli transformant.